Brown Advisory Securities, LLC Gilead Sciences, Inc. Transaction History

Brown Advisory Securities, LLC

$0
Q3 2023

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$59.54 - $68.01 $337,175 - $385,140	-5,663 Reduced 61.95%	3,478 $216,000
Q2 2022 Aug 02, 2022	SELL	$57.72 - $65.01 $126,984 - $143,022	-2,200 Reduced 19.4%	9,141 $566,000
Q1 2022 May 09, 2022	SELL	$57.92 - $72.58 $353,312 - $442,738	-6,100 Reduced 34.98%	11,341 $676,000
Q4 2021 Jan 27, 2022	SELL	$64.88 - $73.64 $361,122 - $409,880	-5,566 Reduced 24.19%	17,441 $1.27 Million
Q3 2021 Nov 12, 2021	SELL	$67.69 - $73.03 $560,473 - $604,688	-8,280 Reduced 26.46%	23,007 $1.61 Million
Q2 2021 Jul 29, 2021	BUY	$63.47 - $69.35 $34,083 - $37,240	537 Added 1.75%	31,287 $2.15 Million
Q1 2021 May 14, 2021	BUY	$60.0 - $68.46 $712,860 - $813,373	11,881 Added 62.97%	30,750 $1.99 Million
Q4 2020 Feb 12, 2021	SELL	$56.65 - $64.55 $551,261 - $628,136	-9,731 Reduced 34.02%	18,869 $1.1 Million
Q3 2020 Nov 13, 2020	SELL	$62.1 - $78.08 $99,981 - $125,708	-1,610 Reduced 5.33%	28,600 $1.81 Million
Q2 2020 Aug 14, 2020	BUY	$72.34 - $84.0 $60,693 - $70,476	839 Added 2.86%	30,210 $2.33 Million
Q1 2020 May 14, 2020	BUY	$62.63 - $80.22 $459,203 - $588,173	7,332 Added 33.27%	29,371 $2.28 Million
Q4 2019 Feb 14, 2020	SELL	$61.62 - $67.78 $57,491 - $63,238	-933 Reduced 4.06%	22,039 $1.43 Million
Q3 2019 Nov 14, 2019	SELL	$62.51 - $69.0 $50,070 - $55,269	-801 Reduced 3.37%	22,972 $1.46 Million
Q2 2019 Aug 12, 2019	BUY	$61.87 - $69.38 $73,439 - $82,354	1,187 Added 5.26%	23,773 $1.61 Million
Q1 2019 May 14, 2019	SELL	$62.53 - $70.05 $16,820 - $18,843	-269 Reduced 1.18%	22,586 $1.47 Million
Q4 2018 Feb 13, 2019	SELL	$60.54 - $79.0 $185,676 - $242,293	-3,067 Reduced 11.83%	22,855 $1.45 Million
Q3 2018 Nov 13, 2018	BUY	$71.28 - $78.92 $58,948 - $65,266	827 Added 3.3%	25,922 $2 Million
Q2 2018 Aug 03, 2018	SELL	$64.88 - $75.68 $5,385 - $6,281	-83 Reduced 0.33%	25,095 $1.78 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $105,108 - $128,138	-1,443 Reduced 5.42%	25,178 $1.9 Million
Q4 2017 Feb 12, 2018	BUY	$71.15 - $83.52 $1.23 Million - $1.44 Million	17,252 Added 184.14%	26,621 $1.91 Million
Q3 2017 Nov 03, 2017	BUY	$72.11 - $85.47 $36,415 - $43,162	505 Added 5.7%	9,369 $754,000
Q2 2017 Aug 14, 2017	BUY	N/A	8,864	8,864 $628,000

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Advisory Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brown Advisory Securities, LLC with notifications on news.

Account